- Home
- VERV vs NBB Comparison
VERV vs NBB Comparison
Compare VERV & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- NBB
- Stock Information
- Founded
- VERV 2018
- NBB 2009
- Country
- VERV United States
- NBB United States
- Employees
- VERV N/A
- NBB N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- NBB Finance Companies
- Sector
- VERV Health Care
- NBB Finance
- Exchange
- VERV Nasdaq
- NBB Nasdaq
- Market Cap
- VERV 475.0M
- NBB 478.3M
- IPO Year
- VERV 2021
- NBB N/A
- Fundamental
- Price
- VERV $5.50
- NBB $15.66
- Analyst Decision
- VERV Strong Buy
- NBB
- Analyst Count
- VERV 4
- NBB 0
- Target Price
- VERV $25.75
- NBB N/A
- AVG Volume (30 Days)
- VERV 1.6M
- NBB 73.9K
- Earning Date
- VERV 11-05-2024
- NBB 01-01-0001
- Dividend Yield
- VERV N/A
- NBB 8.64%
- EPS Growth
- VERV N/A
- NBB N/A
- EPS
- VERV N/A
- NBB N/A
- Revenue
- VERV $24,396,000.00
- NBB N/A
- Revenue This Year
- VERV $97.47
- NBB N/A
- Revenue Next Year
- VERV N/A
- NBB N/A
- P/E Ratio
- VERV N/A
- NBB N/A
- Revenue Growth
- VERV 219.91
- NBB N/A
- 52 Week Low
- VERV $4.31
- NBB $13.67
- 52 Week High
- VERV $19.34
- NBB $16.66
- Technical
- Relative Strength Index (RSI)
- VERV 44.33
- NBB 34.63
- Support Level
- VERV $5.19
- NBB $16.30
- Resistance Level
- VERV $7.40
- NBB $16.50
- Average True Range (ATR)
- VERV 0.65
- NBB 0.19
- MACD
- VERV -0.12
- NBB -0.07
- Stochastic Oscillator
- VERV 7.88
- NBB 2.25
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests primarily in a diversified portfolio of taxable municipal securities.